Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns

Bristol Myers Squibb halts autoimmune drug trials after deaths and life-threatening side effects

Bristol Myers Squibb paused closely watched autoimmune drug research in early June after reports of life-threatening side effects and deaths, notifying regulators, researchers and patient advocacy groups.